Haro Hartounian, head of our biopharma division, will be leading a panel discussion with leaders from Cytiva, GlaxoSmithKline, Amicus Therapeutics and Legend BioTech on the future of Cell & Gene Therapy Manufacturing. We will also be providing a virtual tour and Q&A with our team during the event.
BioNJ Manufacturing Briefing
November 12, 2020
Biopharma manufacturing has been evolving rapidly and even more since COVID-19 set the world asunder. The pandemic combined with the promise of Cell & Gene Therapy and Biopharma 4.0 have opened up a host of opportunities and challenges for manufacturing. This program features industry thought leaders who will review where we are, what lies ahead and what it will take to get there.
Registration is $75 for BioNJ Members and $100 for Future Members.